Merck & Co said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy ...

When topline phase III data was released in November, hinting at the potential of success, Jefferies analyst Akash Tiwari ...

Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents. Halozyme said ...

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a master service agreement (the “Agreement”) ...

Joshua Kaufman, MD, of CDPHP, discusses the significance of long-acting injectables (LAIs) in improving adherence, reducing the risk of relapse, and preventing hospitalizations.

In July 2024, the French government awarded CROSSJECT 6.9 million euros as part of a call for projects under the France 2030 plan, aimed at supporting companies with high growth and innovation ...

Request a Sample Report Now! The global formulation development outsourcing market is being propelled by several key factors ...